학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 56건 | 목록 1~10
Academic Journal
Fusaroli M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. michele.fusaroli2@unibo.it.; Salvo F; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France. francesco.salvo@u-bordeaux.fr.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France. francesco.salvo@u-bordeaux.fr.; Begaud B; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; AlShammari TM; College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia.; Bate A; Global Safety, GSK, Brentford, UK.; Department of Non-Communicable Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.; Battini V; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy.; Brueckner A; Novartis Pharma AG, Basel, Switzerland.; Candore G; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany.; Carnovale C; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy.; Crisafulli S; Department of Medicine, University of Verona, Verona, Italy.; Cutroneo PM; Unit of Clinical Pharmacology, Sicily Pharmacovigilance Regional Centre, University Hospital of Messina, Messina, Italy.; Dolladille C; UNICAEN, EA4650 SEILIRM, CHU de Caen Normandie, Normandie University, Caen, France.; Department of Pharmacology, CHU de Caen Normandie, Caen, France.; Drici MD; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center, Nice, France.; Faillie JL; Desbrest Institute of Epidemiology and Public Health, Department of Medical Pharmacology and Toxicology, INSERM, Univ Montpellier, Regional Pharmacovigilance Centre, CHU Montpellier, Montpellier, France.; Goldman A; Department of Internal Medicine, Sheba Medical Center, Ramat-Gan, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Hauben M; Pfizer Inc, New York, NY, USA.; Department of Family and Community Medicine, New York Medical College, Valhalla, New York, USA.; Herdeiro MT; Department of Medical Sciences, IBIMED-Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal.; Mahaux O; Global Safety, GSK, Brentford, UK.; Manlik K; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany.; Montastruc F; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.; CIC 1436, Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Toulouse University Hospital, Toulouse, France.; Noguchi Y; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.; Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden.; Noseda R; Institute of Pharmacological Sciences of Southern Switzerland, Division of Clinical Pharmacology and Toxicology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Onakpoya IJ; Department for Continuing Education, University of Oxford, Oxford, UK.; Pariente A; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France.; Poluzzi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Salem M; Health Canada, Ottawa, ON, Canada.; Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden.; Centre for Evidence-Based Medicine, Nuffield, Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Trinh NTH; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.; Tuccori M; Tuscany Regional Centre, Unit of Adverse Drug Reaction Monitoring, University Hospital of Pisa, Pisa, Italy.; van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.; van Puijenbroek E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.; Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Khouri C; Pharmacovigilance Department, Université Grenoble Alpes, Grenoble Alpes University Hospital, Grenoble, France.; UMR 1300-HP2 Laboratory, Université Grenoble Alpes, INSERM, Grenoble Alpes University, Grenoble, France.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Academic Journal
Fusaroli M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Salvo F; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France.; Begaud B; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; AlShammari TM; College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia.; Bate A; Global Safety, GSK, Brentford, UK.; Department of Non-Communicable Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.; Battini V; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy.; Brueckner A; Novartis, Basel, Switzerland.; Candore G; Bayer AG, Medical Affairs and Pharmacovigilance, Berlin, Germany.; Carnovale C; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy.; Crisafulli S; Department of Medicine, University of Verona, Verona, Italy.; Cutroneo PM; Unit of Clinical Pharmacology, Sicily Pharmacovigilance Regional Centre, University Hospital of Messina, Messina, Italy.; Dolladille C; UNICAEN, EA4650 SEILIRM, CHU de Caen Normandie, Normandie University, Caen, France.; Department of Pharmacology, CHU de Caen Normandie, Caen, France.; Drici MD; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center, Nice, France.; Faillie JL; Desbrest Institute of Epidemiology and Public Health, Department of Medical Pharmacology and Toxicology, INSERM, Univ Montpellier, Regional Pharmacovigilance Centre, CHU Montpellier, Montpellier, France.; Goldman A; Department of Internal Medicine, Sheba Medical Center, Ramat-Gan, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Hauben M; Pfizer Inc., New York, USA.; Department of Family and Community Medicine, New York Medical College, Valhalla, New York, USA.; Herdeiro MT; Department of Medical Sciences, IBIMED-Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal.; Mahaux O; Global Safety, GSK, Brentford, UK.; Manlik K; Bayer AG, Medical Affairs and Pharmacovigilance, Berlin, Germany.; Montastruc F; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.; CIC 1436, Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Toulouse University Hospital, Toulouse, France.; Noguchi Y; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.; Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden.; Noseda R; Institute of Pharmacological Sciences of Southern Switzerland, Division of Clinical Pharmacology and Toxicology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Onakpoya IJ; Department for Continuing Education, University of Oxford, Oxford, UK.; Pariente A; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France.; Poluzzi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Salem M; Health Canada, Ottawa, Canada.; Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden.; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Trinh NTH; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.; Tuccori M; Tuscany Regional Centre, Unit of Adverse Drug Reaction Monitoring, University Hospital of Pisa, Pisa, Italy.; van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands.; University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology and Economics, Groningen, the Netherlands.; van Puijenbroek E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands.; University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology and Economics, Groningen, the Netherlands.; Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. emanuel.raschi@unibo.it.; Khouri C; Pharmacovigilance Department, Univ. Grenoble Alpes, Grenoble Alpes University Hospital, Grenoble, France. ckhouri@chu-grenoble.fr.; UMR 1300-HP2 Laboratory, Univ. Grenoble Alpes, INSERM, Grenoble Alpes University, Grenoble, France. ckhouri@chu-grenoble.fr.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Academic Journal
Dessart C; Global Safety, GSK, Wavre 1300, Belgium.; Tavares-Da-Silva F; Global Safety, GSK, Wavre 1300, Belgium.; Van Holle L; OpenSourcePV, Court-Saint-Etienne 1490, Belgium.; Mahaux O; Global Safety, GSK, Wavre 1300, Belgium.; Stegmann JU; Global Safety, GSK, Wavre 1300, Belgium.
Publisher: Hindawi Country of Publication: England NLM ID: 101762941 Publication Model: eCollection Cited Medium: Internet ISSN: 2633-4690 (Electronic) Linking ISSN: 26334690 NLM ISO Abbreviation: Adv Pharmacol Pharm Sci Subsets: PubMed not MEDLINE
Academic Journal
Kara V; GSK, 980 Great West Road, London, TW8 9GS, UK. vijay.x.kara@gsk.com.; Powell G; GSK, Research Triangle, NC, USA.; Mahaux O; GSK, Wavre, Belgium.; Jayachandra A; GSK, Bangalore, India.; Nyako N; GSK, 980 Great West Road, London, TW8 9GS, UK.; Golds C; GSK, 980 Great West Road, London, TW8 9GS, UK.; Bate A; GSK, 980 Great West Road, London, TW8 9GS, UK.; Department of Non-Communicable Disease Epidemiology, LSHTM, London, UK.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Academic Journal
Mahaux O; Safety Innovation and Analytics, GSK, Wavre, Belgium. olivia.x.mahaux@gsk.com.; Powell G; Safety Innovation and Analytics, GSK, Durham, NC, USA.; Haguinet F; Safety Innovation and Analytics, GSK, Wavre, Belgium.; Sobczak P; Safety Evaluation and Risk Management, GSK, Warsaw, Poland.; Saini N; Safety Evaluation and Risk Management, GSK, Bangalore, India.; Barry A; University of North Carolina, Chapel Hill, NC, USA.; Mustafa A; University of North Carolina, Chapel Hill, NC, USA.; Bate A; Safety Innovation and Analytics, GSK, London, UK.; London School of Hygiene and Tropical Medicine, University of London, London, UK.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Academic Journal
Weibel D; Erasmus University Medical Center, Post Box 2040, 3000 CA Rotterdam, Netherlands; VACCINE.GRID Foundation, Spitalstrasse 33, Basel, Switzerland. Electronic address: daniel@weibelconsult.com.; Dodd C; Erasmus University Medical Center, Post Box 2040, 3000 CA Rotterdam, Netherlands; Julius Center, University Medical Center Utrecht, Utrecht, Netherlands.; Mahaux O; GSK, Av. Fleming 20, 1300 Wavre, Belgium. Electronic address: olivia.x.mahaux@gsk.com.; Haguinet F; GSK, Av. Fleming 20, 1300 Wavre, Belgium. Electronic address: francois.f.haguinet@gsk.com.; De Smedt T; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium. Electronic address: tom.desmedt@p-95.com.; Duarte-Salles T; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Electronic address: tduarte@idiapjgol.org.; Picelli G; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy. Electronic address: g.picelli@virgilio.it.; Tramontan L; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy; Consorzio Arsenal.IT, Veneto Region, Italy. Electronic address: ltramontan@consorzioarsenal.it.; Danieli G; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy; Consorzio Arsenal.IT, Veneto Region, Italy. Electronic address: gdanieli@consorzioarsenal.it.; Correa A; University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom.; McGee C; University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom; Royal College of General Practitioners Research and Surveillance Centre, 30 Euston Square, London NW1 2FB, UK. Electronic address: c.mcgee@surrey.ac.uk.; Martín-Merino E; Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain. Electronic address: emartinm@aemps.es.; Huerta-Alvarez C; Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain. Electronic address: chuerta@aemps.es.; Berencsi K; Aarhus University Hospital, Olof Palmes Alle 43-45, Aarhus DK-8200, Denmark. Electronic address: klara.berencsi@ndorms.ox.ac.uk.; Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen, Denmark. Electronic address: hde@ssi.dk.; Bollaerts K; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium. Electronic address: kaatje.bollaerts@p-95.com.; Bauchau V; GSK, Av. Fleming 20, 1300 Wavre, Belgium. Electronic address: vincent.g.bauchau@gsk.com.; Titievsky L; Pfizer Inc., New York, NY, United States. Electronic address: lina.titievsky@pfizer.com.; Sturkenboom M; VACCINE.GRID Foundation, Spitalstrasse 33, Basel, Switzerland; Julius Center, University Medical Center Utrecht, Utrecht, Netherlands; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium. Electronic address: m.c.j.sturkenboom@umcutrecht.nl.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Academic Journal
Dodd C; Erasmus University Medical Centre, Postbox 2040, 3000 CA Rotterdam, The Netherlands; Julius Global Health, University Medical Center, Utrecht, Heidelberglaan 100, The Netherlands. Electronic address: c.n.dodd@umcutrecht.nl.; de Ridder M; Erasmus University Medical Centre, Postbox 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: m.deridder@erasmusmc.nl.; Weibel D; Erasmus University Medical Centre, Postbox 2040, 3000 CA Rotterdam, The Netherlands; VACCINE.GRID Foundation, Spitalstrasse 33, Basel, Switzerland. Electronic address: d.weibel@erasmusmc.nl.; Mahaux O; GSK, Building W23, Avenue Flemming 20, 1300 Wavre, Belgium. Electronic address: olivia.x.mahaux@gsk.com.; Haguinet F; GSK, Building W23, Avenue Flemming 20, 1300 Wavre, Belgium. Electronic address: francois.f.haguinet@gsk.com.; de Smedt T; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium. Electronic address: tom.desmedt@p-95.com.; de Lusignan S; University of Surrey, Guildford, Surrey GU2 7XH, UK; Royal College of General Practitioners, Research and Surveillance Centre, 30 Euston Square, London NW1 2FB, UK. Electronic address: s.lusignan@surrey.ac.uk.; McGee C; University of Surrey, Guildford, Surrey GU2 7XH, UK; Royal College of General Practitioners, Research and Surveillance Centre, 30 Euston Square, London NW1 2FB, UK. Electronic address: c.mcgee@surrey.ac.uk.; Duarte-Salles T; Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. Electronic address: tduarte@idiapjgol.org.; Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, DK-23002300, Denmark. Electronic address: hde@ssi.dk.; Huerta-Alvarez C; BIFAP database, Spanish Agency of Medicines and Medical Devices, Madrid, Spain. Electronic address: chuerta@aemps.es.; Martín-Merino E; BIFAP database, Spanish Agency of Medicines and Medical Devices, Madrid, Spain. Electronic address: emartinm@aemps.es.; Picelli G; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy. Electronic address: g.picelli@virgilio.it.; Berencsi K; Aarhus University Hospital, Olof Palmes Alle 43-45, Aarhus DK-8200, Denmark. Electronic address: klara.berencsi@ndorms.ox.ac.uk.; Danieli G; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy.; Sturkenboom M; Julius Global Health, University Medical Center, Utrecht, Heidelberglaan 100, The Netherlands; VACCINE.GRID Foundation, Spitalstrasse 33, Basel, Switzerland; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium. Electronic address: m.c.j.sturkenboom@umcutrecht.nl.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Academic Journal
Tavares-Da-Silva F; GSK, Avenue Fleming 20, 1300, Wavre, Belgium. fernanda.tavares@gsk.com.; Mahaux O; GSK, Avenue Fleming 20, 1300, Wavre, Belgium.; Van Holle L; GSK, Avenue Fleming 20, 1300, Wavre, Belgium.; UCB Pharma, 1420, Braine-l'Alleud, Belgium.; Haguinet F; GSK, Avenue Fleming 20, 1300, Wavre, Belgium.; Seifert H; GSK, 5 Crescent Drive, Philadelphia, PA, USA.; Stegmann JU; GSK, Avenue Fleming 20, 1300, Wavre, Belgium.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Mahaux, O.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어